Boehringer Ingelheim, Click Therapeutics expand their collaboration to develop digital therapeutics for schizophrenia
The partnership aims to provide additional treatment options to those living with schizophrenia, where there remains a significant unmet need...
The agreement utilizes Inovalon and Avalere's combined breadth of healthcare capabilities and integrated platform supporting greater data integration and analytics.
Patients will have the opportunity to enroll in a new program to determine how Propeller's hi-tech tool can impact adherence rates and patient engagement.
The two parties will start with focus on chronic obstructive pulmonary disease (COPD) to make it easier for doctors and patients to work together.